CN Patent

CN115671041B — 一种浓缩型乳糖醇口服液及其制备方法与应用

Assigned to Niubaiteng Beijing Medicine Technology Co ltd · Expires 2024-03-01 · 2y expired

What this patent protects

本发明公开了一种浓缩型乳糖醇口服液及其制备方法与应用，属于医药技术领域。所述浓缩型乳糖醇口服液主要是由乳糖醇、碳酸氢钠、氯化钠和氯化钾组成。所述口服液因不加抑菌剂或防腐剂而能保证产品的安全性和稳定性，且高度浓缩能够减小患者服用量从而提高临床顺应性，并通过加入一定量的电解质盐以降低电解质紊乱的风险，该方法制备简单，易于产业化生产。

USPTO Abstract

本发明公开了一种浓缩型乳糖醇口服液及其制备方法与应用，属于医药技术领域。所述浓缩型乳糖醇口服液主要是由乳糖醇、碳酸氢钠、氯化钠和氯化钾组成。所述口服液因不加抑菌剂或防腐剂而能保证产品的安全性和稳定性，且高度浓缩能够减小患者服用量从而提高临床顺应性，并通过加入一定量的电解质盐以降低电解质紊乱的风险，该方法制备简单，易于产业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN115671041B
Jurisdiction
CN
Classification
—
Expires
2024-03-01
Drug substance claim
No
Drug product claim
No
Assignee
Niubaiteng Beijing Medicine Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.